IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its position in shares of IQVIA Holdings Inc. (NYSE:IQVFree Report) by 4.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,690 shares of the medical research company’s stock after selling 1,059 shares during the quarter. Mutual of America Capital Management LLC’s holdings in IQVIA were worth $5,055,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Vestmark Advisory Solutions Inc. lifted its stake in IQVIA by 10.9% during the second quarter. Vestmark Advisory Solutions Inc. now owns 1,800 shares of the medical research company’s stock worth $405,000 after purchasing an additional 177 shares during the last quarter. Parallel Advisors LLC lifted its stake in IQVIA by 6.8% in the second quarter. Parallel Advisors LLC now owns 8,793 shares of the medical research company’s stock valued at $1,977,000 after buying an additional 557 shares during the last quarter. Kentucky Retirement Systems bought a new stake in shares of IQVIA during the third quarter valued at about $2,994,000. LPL Financial LLC raised its stake in shares of IQVIA by 3.8% during the second quarter. LPL Financial LLC now owns 83,491 shares of the medical research company’s stock valued at $18,766,000 after purchasing an additional 3,025 shares in the last quarter. Finally, Brown Advisory Inc. raised its stake in shares of IQVIA by 27.6% during the second quarter. Brown Advisory Inc. now owns 1,510 shares of the medical research company’s stock valued at $339,000 after purchasing an additional 327 shares in the last quarter. 86.82% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Kevin C. Knightly sold 13,117 shares of IQVIA stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $214.03, for a total value of $2,807,431.51. Following the transaction, the insider now owns 7,347 shares of the company’s stock, valued at approximately $1,572,478.41. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on IQV. Guggenheim cut their price objective on shares of IQVIA from $253.00 to $220.00 and set a “buy” rating on the stock in a research note on Friday, November 3rd. Morgan Stanley cut their price objective on shares of IQVIA from $240.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, November 3rd. Truist Financial lifted their price objective on shares of IQVIA from $240.00 to $286.00 and gave the company a “buy” rating in a research note on Thursday, January 4th. Citigroup lifted their price objective on shares of IQVIA from $190.00 to $225.00 and gave the company a “neutral” rating in a research note on Monday, December 11th. Finally, JPMorgan Chase & Co. lowered their target price on IQVIA from $262.00 to $239.00 and set an “overweight” rating on the stock in a report on Monday, November 13th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $244.31.

Check Out Our Latest Stock Report on IQVIA

IQVIA Trading Down 0.1 %

Shares of IQV opened at $217.88 on Tuesday. The business’s 50-day moving average price is $219.72 and its 200 day moving average price is $211.12. The stock has a market capitalization of $39.76 billion, a P/E ratio of 36.62, a P/E/G ratio of 2.49 and a beta of 1.48. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $234.92. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 2.12.

IQVIA Company Profile

(Free Report)

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

See Also

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQVFree Report).

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.